Evolution historique des Biotechs cotées sur Euronext (uniquement en France, Belgique et Pays-Bas

 

		Pays	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	IPO
	AB Science	FR	-38%	265%	55%	-62%	-39%	12%	0%	-16%	-24%	198%	-30%	-37%						-7%
	Abivax	FR	-26%	53%	90%	37%	37%	-55%	-33%											13%
	Ablynx	BE			opa->	117%	92%	-32%	72%	27%	18%	63%	-57%	1%	73%	-34%	-3%			OPA
	Acacia	BE	-50%	26%	65%	-62%														-65%
	Adocia	FR	0%	-16%	-40%	13%	-76%	-17%	39%	695%	-42%	-35%								-48%
	Advicenne	FR	-27%	14%	-7%	-32%	-1%													-48%
	Argen-X	BE	5%	69%	69%	58%	229%	43%	48%	-4%										2899%
	Asit	BE	0%	-29%	-81%	-55%	-43%	-6%												-97%
	Biophytis	FR	-46%	411%	-88%	-64%	22%	-66%	91%											-92%
	Bone	BE	-65%	-29%	-19%	-44%	0%	-60%	22%											-96%
	Cellectis	FR	-69%	56%	4%	-38%	47%	-42%	111%	413%	-68%	8%	-17%	-32%	48%	-19%	-39%			-48%
	Celyad	BE	-51%	-32%	-42%	-52%	94%	-63%	41%	34%	35%									-82%
	Abionyx	FR	217%	191%	-31%	-75%	-78%	-32%	3%											-75%
	DBV	FR	19%	-78%	85%	-75%	-37%	0%	41%	302%	32%	-9%								-42%
	Eurobio	FR	25%	261%	53%	-35%	-24%	-35%	-21%	-28%	-27%	-15%	-49%	-44%	32%	-44%	-31%	-5%	23%	-79%
	Erytech	FR	-66%	6%	7%	-66%	35%	-46%	-8%	154%	-13%									-80%
	Galapagos	BE	-48%	-57%	132%	3%	30%	7%	261%	0%	-7%	49%	-14%	42%	103%	-49%	-21%	8%	25%	474%
	GeNeuro	FR	25%	-24%	8%	-40%	-44%	-17%												-74%
	Genfit	FR	-27%	-77%	2%	-26%	14%	-35%	-19%	312%	175%	83%	-61%	-42%	8%	-41%	-31%	83%		-76%
	Genomic Vision	FR	-62%	132%	6%	-90%	-25%	-49%	-27%	-24%										-98%
	GenSight	FR	-20%	186%	-25%	-46%	-20%	-5%												-30%
	Genkyotex	FR	#N/A	#N/A	#N/A	#N/A	-34%	-62%	18%	-23%										#N/A
	Hybrigenics	FR	-41%	120%	25%	-87%	-27%	-21%	-38%	-5%	92%	-3%	-32%	-53%	9%	-64%	0%			-98%
	Innate	FR	25%	-42%	-20%	54%	-67%	8%	55%	61%	124%	58%	14%	-53%	72%	-61%	-41%	129%		-10%
	Integragen	FR	-35%	103%	-9%	-56%	-25%	-25%	-17%	14%	-34%	-13%	2%	-21%						-85%
	Inventiva	FR	2%	219%	-35%	19%	-42%													40%
	Kiadis	NL	opa>	165%	-74%	-4%	-6%	-31%	-1%											-100%
	Lysogene	FR	-33%	46%	14%	-54%	-44%													-74%
	MDXHealth	BE	7%	-14%	-44%	-42%	-33%	16%	-8%	55%	39%	38%	-3%	-66%	-36%	-31%	-21%	51%		-89%
	Medincell	FR	-5%	48%	3%	-10%														33%
	Mithra	BE	4%	-25%	31%	93%	14%	-11%	-15%											86%
	Nanobiotix	FR	-46%	67%	-29%	-23%	-4%	-3%	-10%	208%	-21%	8%								19%
	Neovacs	FR	-87%	-48%	-71%	-58%	-43%	-28%	-7%	-47%	-9%	-35%	-23%							-100%
	Nicox	FR	-30%	0%	-13%	-50%	19%	-6%	-6%	-22%	1%	121%	-54%	-63%	-26%	-32%	-52%	553%	-15%	-89%
	Novacyt	FR	-56%	5665%	-56%	-47%	-38%	-63%	-36%	-40%	-4%	-7%								-51%
	Oncodesign	FR	-31%	22%	47%	-45%	-19%	-21%	153%	-1%										12%
	Onxeo	FR	-38%	20%	-37%	-24%	-57%	-33%	-35%	17%	-11%	44%	-41%	14%	94%	-73%	-35%	6%	0%	-97%
	Ose Immuno.	FR	58%	95%	9%	-15%	-46%	-16%	-19%											4%
	Pharming	NL	-46%	-19%	107%	-38%	421%	-23%	-28%	152%	-44%									-99%
	Pharnext	FR	-97%	-42%	-46%	29%	-14%	-10%												-99%
	Poxel	FR	-21%	-48%	140%	-24%	-6%	-47%	84%											-24%
	Predilife	FR	-3%	-9%	-15%	1%														-25%
	Vivoryon	NL	93%	66%	117%	-76%	-41%	-27%	29%	-4%										-13%
	Quantum	FR	-12%	45%	-37%	74%	-57%	-14%	47%	29%										-29%
	Sensorion	FR	17%	76%	-16%	-74%	-23%	-45%	92%											-58%
	Theradiag	FR	-9%	127%	21%	-59%	-39%	8%	-15%	-18%										-62%
	Theranexus	FR	-72%	513%	-83%	19%	-5%													-67%
	Oxurion	BE	-23%	-13%	-19%	6%	34%	-30%	-47%	-67%	-54%	121%	-18%	47%	103%	-27%	-29%	160%		-59%
	Tigenix	BE			opa>	84%	37%	-41%	113%	0%	-44%	26%	-43%	-67%	62%	-51%	-17%			OPA
	Transgene	FR	59%	6%	-42%	-5%	6%	6%	-65%	-23%	4%	6%	-45%	-32%	74%	-19%	17%	80%	6%	-95%
	TxCell	FR			opa>	68%	-36%	-64%	3%	3%										OPA
	Valneva	FR	258%	202%	-19%	11%	-10%	-19%	-16%	3%	-39%	18%	-25%	-14%	131%	-50%	-25%			161%
	▶ moy. Euronext :		#N/A	#N/A	#N/A	#N/A	1%	-24%	21%	67%	3%	34%	-29%	-26%	53%	-43%	-23%	118%	8%	#N/A
	▶ moy. FR :		#N/A	#N/A	#N/A	#N/A	-22%	-26%	13%	85%	8%	27%	-30%	-34%	49%	-45%	-26%	141%	4%	#N/A
	▶ moy. BE :		-25%	-12%	10%	10%	45%	-18%	54%	6%	-2%	59%	-27%	-9%	61%	-38%	-18%	73%	25%	330%